Carnosine,carnosinase gene polymorphism and diabetic nephropathy

Xue-yao YIN,Hong LI
DOI: https://doi.org/10.3760/cma.j.issn.1673-4157.2011.02.007
2011-01-01
International Journal of Endocrinology and Metabolism
Abstract:Carnosine is an endogenously synthesized dipeptide commonly present in mammalian tissue,which can inhibit the thickening of glomerular capillary basement membrane and glomerular sclerosis by scavenging free oxygen radical, inhibiting formation of advanced glycation end products and cytokines, and inhibiting the renin-angiotensin system. It is considered as a protective factor for diabetic nephropathy.Carnosine is degraded predominantly by carnosinase which is coded by CNDP1 and CNDP2. Several studies have shown that the carnosinase gene polymorphism may affect the level and activities of carnosinase, and the current researches have focused on the (CTG) n in CNDP1 exon 2. Studying on the molecular biological mechanisms of carnosine and carnosinase may provide a new pathway to prevent, diagnose, and treat diabetic nephropathy.
What problem does this paper attempt to address?